Plexium, Inc. filed a Form D with the Securities and Exchange Commission on 2025-08-25.
Plexium, Inc. filed a Form D notice of an exempt securities offering with the SEC on August 25, 2025. The filing reports $60.12M sold. Its industry group is Biotechnology. It names Michael Martin (Executive Officer, Director), Michael Grey (Director), Patrick Rivers (Director) (SEC Form D, August 25, 2025).
Is this your company?
Sell to companies like Plexium, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-08-25 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Plexium, Inc.
Free to see. No signup.
More on the people and the money behind Plexium, Inc., from the filings we hold.
Biotechnology raises by companies based in California, filed in August 2025, largest first.
Get an email when Plexium, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Plexium, Inc. raises, hires or launches. No email unless you switch it on.
Watch Plexium, Inc. →Get the full cited report on Plexium, Inc.
What the filing shows about Plexium, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Plexium, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Plexium, Inc.'s address as 9330 Scranton Road, Suite 500, San Diego, CA 92121.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Plexium, Inc. is a registered filer with the SEC (CIK 2082715) and has filed since 2025-08-25. 1 filing is on record, the latest on 2025-08-25.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Plexium, Inc.'s Form D of 2025-08-25 names Michael Martin, Michael Grey, Patrick Rivers and 6 more as its officers, directors or promoters.
Its new offerings report $60.12M sold across 1 offering, as its own filings state.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
Michael Martin is named as Executive Officer and Director on the Form D that Plexium, Inc. filed with the SEC on 25 August 2025, one of 9 people that filing names.
Michael Grey is named as Director on the Form D that Plexium, Inc. filed with the SEC on 25 August 2025, one of 9 people that filing names.
Patrick Rivers is named as Director on the Form D that Plexium, Inc. filed with the SEC on 25 August 2025, one of 9 people that filing names.
Leon Chen is named as Director on the Form D that Plexium, Inc. filed with the SEC on 25 August 2025, one of 9 people that filing names.
Gorjan Hrustanovic is named as Director on the Form D that Plexium, Inc. filed with the SEC on 25 August 2025, one of 9 people that filing names.
Serge Messerlian is named as Director on the Form D that Plexium, Inc. filed with the SEC on 25 August 2025, one of 9 people that filing names.
Rob Hopfner is named as Director on the Form D that Plexium, Inc. filed with the SEC on 25 August 2025, one of 9 people that filing names.
Cariad Chester is named as Director on the Form D that Plexium, Inc. filed with the SEC on 25 August 2025, one of 9 people that filing names.
Stephen Mullennix is named as Executive Officer on the Form D that Plexium, Inc. filed with the SEC on 25 August 2025, one of 9 people that filing names.
9 people named on the filing — 2 holding an executive role and 7 as directors only.
Named as of the 2025-08-25 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Plexium, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Plexium, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Plexium, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Plexium, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Plexium, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Plexium, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in San Diego
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/plexium-inc-form-d-25000001